Maternal Serum Alpha-fetoprotein Level May Predict the Presence of Morbid Adherent Placenta

rasha medhat abdul-hady150 enrolled

Overview

The aim of the study is to compare between alpha-fetoproteine as a biological marker and between ultrasound and Doppler in prediction of morbid adherent placenta.

in pregnant women withe previous cesarean section, placenta previa and ultrasonographic finding of an abnormally adherent placenta dose maternal serum alpha-fetoprotein predict prenataly the presence of morbid adherent placenta accurately?

Study Type

OBSERVATIONAL

Enrollment

150

Conditions

Placenta Accreta

Interventions

Serum alpha-fetoproteineDIAGNOSTIC_TEST

Midtrimesteric serum alpha-fetoprotein mesurment with 2D US and 3D power Doppler with MS US scan .

Eligibility

Sex: FEMALEMin age: 20 YearsMax age: 39 Years

Medical Language ↔ Plain English

Inclusion Criteria: * pregnant women with history of scarred uterus * plcenta previa covering the scar of previous caesarean section as diagnosed by 2DU/S * Gestational age from 28wks to full term Exclusion Criteria: * pregnant women with fetus with congenital anomalies * pregnant women with ovarian swelling * pregnant women with medical disease

Locations (1)

Ain shams university maternity hospital

Cairo, Egypt

Outcomes

Primary Outcomes

Maternal serum alpha-fetoprotein

ng/ml or MOM(Multiple of the median)

Time frame: From 28weeks to 37 weeks

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.